DBV Technologies | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 201.55M 28.99M 2024-09
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
DBV Technologies USD 30.91M 3.53M 2024-09
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Incyte USD 1.89B 244.96M 2025-03
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
United Therapeutics USD 721.5M 16.6M 2025-03



DBV Technologies Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.